
|Videos|March 17, 2021
Refining Combination Strategies in Metastatic RCC
Author(s)Toni K. Choueiri, MD, Robert J. Motzer, MD
Drs Toni Choueiri and Robert J. Motzer reflect on recent data supporting the use of TKI/I-O combination regimens for frontline treatment of metastatic renal cell carcinoma.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
GLP-1 Receptor Agonists Show Modest Reduction in HR+ Breast Cancer Incidence
2
84 Exceptional Responders in De Novo Metastatic Breast Cancer (dnMBC) Drug Cessation in Patients With HER2-Positive Metastatic Breast Cancer; Multicenter Retrospective Study
3
BCMA CAR T-Cell Therapy Improves OS Vs Teclistamab in Multiple Myeloma
4
Radiation Oncology Trials You May Have Missed at ASCO 2026
5





































































